vTv Therapeutics Inc. (VTVT) delivered a return of 126.20% over the past year. Since VTVT does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in vTv Therapeutics Inc. one year ago would be worth $22,620 today, representing a gain of $12,620.

vTv Therapeutics Inc. (VTVT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For VTVT, the total return equals the price-only return.

Yes, vTv Therapeutics Inc. (VTVT) outperformed the S&P 500 by 105.36 percentage points over the past year. VTVT delivered a total return of 126.20%, compared to the S&P 500's 20.84%. This 105.36pp alpha means investors in VTVT earned more than a passive S&P 500 index fund.

vTv Therapeutics Inc. (VTVT) experienced a maximum drawdown of -32.06% over the past year, declining from its peak on 2026-01-06 to its trough on 2026-02-06. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are vTv Therapeutics Inc. (VTVT)'s long-term returns with dividends reinvested. Over 10 years, the total return is -85.0% (-17.3% CAGR) — $10,000 would have grown to $1,504. Over 20 years: -91.8% total return (-11.8% CAGR) — $10,000 → $820. Over 30 years: -91.8% total return (-8.0% CAGR) — $10,000 → $820. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

vTv Therapeutics Inc.'s best calendar year was 2025 with a total return of 194.7%. Its worst year was 2023 with a total return of -60.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 255.0 percentage points.